Progressive Supranuclear Palsy (PSP) Therapies mar..

created a new article

3 months ago - Translate

Progressive Supranuclear Palsy (PSP) Therapies market Size, Share and Industry Trends by 2030 | #progressive Supranuclear Palsy (PSP) Therapies

Progressive Supranuclear Palsy (PSP) Therapies market Size, Share and Industry Trends by 2030

Progressive Supranuclear Palsy (PSP) Therapies market Size, Share and Industry Trends by 2030

In 2019, owing to the failure to meet the desired endpoints, two big pharma players, Abbvie and Biogen announced their decision to terminate the development of their pipeline anti-tau antibodies for PSP, namely ABBV-8E12 and gosuranemab, respectively.